This document is an excerpt from the EUR-Lex website
Document C:2003:250:TOC
Official Journal of the European Union, C 250, 18 October 2003
Official Journal of the European Union, C 250, 18 October 2003
Official Journal of the European Union, C 250, 18 October 2003
Official Journal of the European Union | ISSN
1725-2423 C 250 Volume 46 18 October 2003 |
English edition | Information and Notices | ||
Notice No | Contents | Page | |
I Information | |||
Council | |||
2003/C 250/01 | Council Conclusions of 22 September 2003 on reinforcing the competitiveness of the European-based pharmaceutical industry | 1 | |
2003/C 250/02 | Council Resolution of 22 September 2003 on investing in research for European growth and competitiveness | 2 | |
Commission | |||
2003/C 250/03 | Euro exchange rates | 4 | |
2003/C 250/04 | List of bodies or public authorities in charge of inspection provided for in Article 15 of Regulation (EEC) No 2092/91 | 5 | |
2003/C 250/05 | Prior notification of a concentration (Case COMP/M.3152 — ThyssenKrupp/Mercedes Lenkungen) — Candidate case for simplified procedure (1) | 21 | |
2003/C 250/06 | Prior notification of a concentration (Case COMP/M.3295 — Atos Origin/Sema Group) — Candidate case for simplified procedure (1) | 22 | |
2003/C 250/07 | Prior notification of a concentration (Case COMP/M.3279 — Generali/Zurich Financial Services) — Candidate case for simplified procedure (1) | 23 | |
2003/C 250/08 | Final report of the hearing officer in case COMP/38.044/D3 — NDC/IMS (pursuant to Article 15 of Commission Decision 2001/462/EC, ECSC of 23 May 2001 on the terms of reference of Hearing Officers in certain competition proceedings — OJ L 162, 19.6.2001, p. 21) | 24 | |
EN | (1) Text with EEA relevance |